Liu CY, Hsu CC, Huang TT, Lee CH, Chen JL, Yang SH, Jiang JK, Chen WS, Lee KD, Teng HW*. ER Stress-Related ATF6 Upregulates CIP2A and Contributes to Poor Prognosis of Colon Cancer. Mol Oncol 2018 Jul. [Epub ahead of print] (IF: 5.264; Oncology 46/222)
Teng HW, Hung MH, Chen LJ, Chang MJ, Hsieh FS, Tsai MH, Huang JW, Lin CL, Tseng HW, Kuo ZK, Jiang JK, Yang SH, Shiau CW, Chen KF*. Protein Tyrosine Phosphatase 1B Targets PITX1/p120RasGAP Thus Showing Therapeutic Potential in Colorectal Carcinoma. Sci Rep 2016 Oct; 6(): 35308. (IF: 5.228; Multidisciplinary Sciences 7/63)
Lu CS, Lin JK, Chen WS, Lin TC, Jiang JK, Yang SH, Wang HS, Chang SC, Lan YT, Lin CC, Lin HH, Teng HW*. Intraperitoneal Ziv-Aflibercept Effectively Manages Refractory Ascites in Colorectal Cancer Patients. Oncotarget 2017 May; 8(22): 36707-15. Epub 2016 Nov. (IF: 5.168; Oncology 44/217; Cell Biology 48/189)
Chen KF, Yen CC, Lin JK, Chen WS, Yang SH, Jiang JK, Lan YT, Lin CC, Yu HC, Hsu HM, Lin WL, Teng HW*. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) is an Independent Prognostic Marker in Wild-Type KRAS Metastatic Colorectal Cancer after Colorectal Liver Metastasectomy. BMC Cancer 2015 Apr; 15(): 301. (IF: 3.265; Oncology 85/213)
Chen HM, Lin JK, Chen WS, Jiang JK, Yang SH, Lan YT, Lin CC, Teng HW*. Reduced-Intensity FOLFOXIRI in Treating Refractory Metastatic Colorectal Cancer: A Pilot Study. Am J Clin Oncol 2017 Jun; 40(3): 260-5. (IF: 3.259; Oncology 96/217)
Lu HJ, Lin JK, Chen WS, Jiang JK, Yang SH, Lan YT, Lin CC, Liu CA, Teng HW*. The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease? PLoS One 2015 Jun; 10(6): e0130345. (IF: 3.057; Multidisciplinary Sciences 11/63)
Yang YH, Teng HW, Lai YT, Li SY, Lin CC, Yang AC, Chan HL, Hsieh YH, Lin CF, Hsu FY, Liu CK, Liu WS*. Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study. PLoS One 2015 Sep; 10(9): e0137914. (IF: 3.057; Multidisciplinary Sciences 11/63)
Lu HJ, Lin JK, Chen WS, Jiang JK, Yang SH, Lan YT, Lin CC, Chang SC, Teng HW. Primary Tumor Location Is An Important Predictive Factor for Wild-Type KRAS Metastatic Colon Cancer Treated with Cetuximab as Front-Line Bio-Therapy. Asia Pac J Clin Oncol 2016 Sep; 12(3): 207-15. (IF: 1.722; Oncology 169/213)